(Q72467445)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

A randomized controlled trial of thymopentin therapy in patients with chronic hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

randomized controlled trial

26 October 2019

main subject

1 reference

1 reference

1 reference

P Pontisso

5

1 reference

ORCID Public Data File 2021

Alfredo Alberti

1 reference

ORCID Public Data File 2021

author name string

G Fattovich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

G Giustina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

A Alberti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M Guido

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

S Favarato

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

L Benvegnù

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

A Ruol

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 September 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

361-366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

Natural history and prognostic factors for chronic hepatitis type B

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

A Synthetic Pentapeptide with Biological Activity Characteristic of the Thymic Hormone Thymopoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Phase variation in the modulation of the human immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long-term follow-up study of 138 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi-centre randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Therapy for chronic hepatitis B with lymphoblastoid interferon-alpha and levamisole

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Pilot study of recombinant human interleukin 2 for chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Levamisole therapy in chronic type B hepatitis. Results of a double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Effect of thymosin immunostimulation with and without corticosteroid immunosuppression on chimpanzee hepatitis B carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Immunotherapy of patients with chronic virus B hepatitis. I. Maturation of human T-lymphocytes under influence of calf thymic hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980314-9

7 January 2021

10.1016/S0168-8278(05)80314-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7836705%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference